BRAF Targeted Treatment for Metastatic Melanoma, Resistance Patterns, and Future Hopes
11 November, 2021
Gundersen Medical Foundation presents this on-demand CME accredited by the Wisconsin Medical Society.
Presenter: Swapna Narayana, MD
Credit Designation
- The Gundersen Health System designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
- The Gundersen Lutheran Medical Foundation Inc. designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Classifications
- This activity includes 1 hours of Commission on Cancer education.
You May Also Like
Surviving cancer starts at diagnosis and continues after treatment – earlier survivorship care can help patients feel better and live longer
10.23.2026
Marci Lee Nilsen,
Cancer in Nevada: What the latest national data means for prevention, early detection and survivorship
01.26.2026
Each year, the American Cancer Society releases its annual
Cancer drugs included in federal Medicare price negotiations
12.10.2025
Nevada seniors are set to see lower prices on more of the medications they rely on. This week, U.S. Sen.